Since NADP+ shares similar molecular mechanism of PARP inhibition as chemically synthesized PARP inhibitors, NADP+, an endogenous PARP inhibitor, additively functions with PARP inhibitors to suppress tumor growth by abolishing DNA damage repair. This evidence concerns the gene PARP1 and neoplasm.